Founder

Although technological advancement has brought comfort to human life, there is still significant room for improvement in the development of medicines for treating diseases. For decades, Western countries have made limited breakthroughs in the development of drugs for major diseases, particularly cancer. Thus, cancer remains one of the leading causes of human suffering and reduced life expectancy. I served in the Department of Biochemistry and the Graduate Institute of Biochemistry at Kaohsiung Medical University for 23 years and accumulated decades of experience in anticancer drug research. With profound and unique insights into cancer cell mechanisms and gene regulation, I felt compelled to transform this knowledge into practical medicines that could genuinely help humanity—giving greater meaning and value to life. Therefore, I transitioned from academia into biotechnology, dedicating myself to developing botanical new drugs, especially for diseases that are currently difficult to treat clinically, including cancer and liver, gallbladder, and kidney disorders.

During my tenure at Kaohsiung Medical University, I received research grants annually from the National Science Council and the Department of Chinese Medicine & Pharmacy, and was awarded multiple first-class research incentives. I also received research grants and outstanding academic awards from Tulane Cancer Center in the United States. I was the first in the world to publish an international academic paper demonstrating the use of botanical compounds to regulate and induce apoptosis (cellular suicide) in cancer cells. I have supervised dozens of master’s and doctoral students, many of whom now serve in government, academia, and industry. As a reviewer for several international scientific journals, I gained further recognition. In 2000, after receiving anti-cancer drug invention patents from both the United States and Taiwan’s Department of Health, I was featured widely in television, professional media, and public forums. At the same time, I realized deeply the helplessness of cancer patients and their desperate need for effective anticancer therapies. Therefore, with decades of experience accumulated, I established the “Plant Bioactivity and Mechanism Research Center” within the company to ensure continuous advancement in cancer and drug development research.

The botanical new drugs developed by our company have completed several human clinical trials for treating skin cancer and viral warts. We are currently developing a new drug for the treatment of malignant ascites, with the expectation of achieving further breakthroughs in cancer therapy. We will spare no effort in developing high-quality and effective botanical new drugs to help those in need. Every product we offer is developed and manufactured with integrity, ensuring that our brand earns the trust of consumers and reaches new heights in the global botanical drug and related product markets.